SYS6006 in Combination With Enlonstobart Injection Versus Enlonstobart Injection in Participants With Advanced Solid Tumors

Clinical trial NCT07622225 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07622225
Sponsor: CSPC Megalith Biopharmaceutical Co.,Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2026-05-29
Primary completion: 2028-12-31
Enrollment: 264

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.